Since we tend to be pretty America-centric over here, we wanted to shine a spotlight on the annual conference for the European Association for the Study of Diabetes (EASD), which is Europe’s equivalent to the American Diabetes Association. EASD is a huge professional org for doctors, researchers, nurses, students, and so on, with 7,000 members — from 110 different countries!
In addition to the annual conference, the EASD also produces their own trade publication, Diabetologia,…
Read more »
By
WilD on
September 10, 2011
Meds, meds, meds. What’s a PWD to do? They can be confusing and scary, and leave you wondering if the benefits outweigh the risks. We’re no doctors, but we can talk about known side effects and the trade-off’s many patients have to make.
Join us this week for a pill-popping edition of our diabetes advice column, Ask D’Mine, hosted by veteran type 1, diabetes author and community educator Wil Dubois.
{Need help navigating life with…
Read more »
Finding a less invasive method of taking insulin seems to be all the rage these days. Although the once-hailed Exhubera fizzled away, researchers have not given up on the “holy grail” of oral insulin. Aside from Mannkind’s Afrezza, which is delayed and controversial, there’s another kind of oral insulin that might be making its mark in the diabetes marketplace… eventually.
Meet MonoSol Rx.
This New Jersey-based company has created PharmFilm, a thin, postage-sized film that…
Read more »
The world of type 2 diabetes drugs is wacky indeed. While Amylin’s long-acting version of Byetta — called Bydureon and predicted by many experts to become a blockbuster — is still held up at FDA, the agency approved a new oral drug earlier this month that is reportedly unremarkable except in the lawsuit it has spurred.
The drug is called linagliptin, brand name Tradjenta, a new oral DPP-4 inhibitor from Eli Lilly and Boehringer that…
Read more »
Society has many myths and misconceptions about people with diabetes. But even our own community can have some rather interesting “prejudices” about what diabetes is like for other people. After an article on a so-called “Civil War” between type 1 and type 2 diabetes appeared in the Chicago Tribune last fall, we at the ‘Mine decided to start sharing some personal stories of people living with type 2 diabetes, in order to better understand this…
Read more »
